SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions
Qing Deng(The University of Texas MD Anderson Cancer Center), Michael R. Green(Dana-Farber Cancer Institute)
Cited by 28
Related Papers
Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines
|Molecular Cancer Therapeutics|2009|46
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells
|Cell Reports Medicine|2023|40
Transcription and signalling pathways involved in BCR–ABL‐mediated misregulation of 24p3 and 24p3R
|The EMBO Journal|2009|39